Oracle Reiterates its PeopleSoft Buy Stance

Published: Nov 11, 2003
Updated: Feb 2, 2021
3 minute read
eWeek のコンテンツおよび製品のおすすめは、編集上の独立性を保っています。パートナーへのリンクをクリックすると、当社が報酬を得る場合があります。 詳細を見る

Quashing online rumors, Oracle Corp said Tuesday the company has no intention of stepping back from its $7.3 billion hostile takeover bid for PeopleSoft Inc.

Despite an amended filing on Monday that requested the Delaware Chancery Court to provide injunctive relief against PeopleSofts Customer Assurance Program—which could be prohibitively costly to Oracle should it acquire rival PeopleSoft—Oracle said it is still moving forward with the deal.

Oracle, of Redwood Shores, Calif., originally filed suit against PeopleSoft earlier this summer in an attempt to have the company remove its so-called Poison Pill anti-takeover stipulation.

The amended suit looks to force PeopleSoft to not only dismantle its Poison Pill, but to end its “unprecedented rebate program.” The company also filed a separate request to the court this week requesting an expedited decision, signaling perhaps the next move in the battle, which would be a decision from the Department of Justice regarding the competitive nature of the acquisition.

PeopleSoft initially enacted its Customer Assurance Program in June, after Oracles CEO Larry Ellison was quoted as saying he would discontinue support of PeopleSofts software should the acquisition prove successful.

In October PeopleSoft, of Pleasanton, Calif., modified that program to include refunds for customers between two and five times the total arrangement fees—language that could, in the end, include such expensive line items as implementation, integration and consulting fees.

The upgraded program also stipulates refunds will be granted if PeopleSoft is acquired within two years—versus one year in the original offer—and the acquiring company reduces support for PeopleSofts software within four years, versus two years in the initial program.

While PeopleSoft officials contend that the assurance program is of no consequence to Oracle—in the event that its successful in its acquisition attempts—because Oracle has already said it would maintain support of PeopleSofts product line.

“An acquirer would not have to make any payments to any customers if they continue the level of support that is generated from PeopleSoft,” said Steve Swasey, PeopleSoft spokesman. “So if PeopleSoft is acquired by Oracle, they would never have to pay a penny if they continue to support [PeopleSofts software development and support].”

Advertisement

Oracle, for its part, contends the program is hitting PeopleSofts bottom line.

“PeopleSoft management entrenchment tactics continue to destroy the value of the company for its shareholders,” said Deborah Lilienthal, an Oracle spokeswoman. “We remain committed to the transaction.”

In the meanwhile, some PeopleSoft shareholders are taking umbrage at the upgraded assurance program, filing a separate suit in the same Delaware court late last week. That suit is an effort to force PeopleSoft to cease the customer assurance program, saying its draconian in its effect.

PeopleSoft, for its part, has ongoing litigation against Oracle in a suit that would force Oracle to drop its acquisition bid. The next hearing date for that case, filed in the Alameda County, Calif. Court, is December 5.

A court date in Oracles case against PeopleSoft is unavailable at this time, according to the Chancery Court.

Discuss This in the eWEEK Forum

Editors note: This story has been updated since its original posting to include information from Oracle.

eWeek Logo

eWeek has the latest technology news and analysis, buying guides, and product reviews for IT professionals and technology buyers. The site's focus is on innovative solutions and covering in-depth technical content. eWeek stays on the cutting edge of technology news and IT trends through interviews and expert analysis. Gain insight from top innovators and thought leaders in the fields of IT, business, enterprise software, startups, and more.

TechnologyAdvice が所有・運営しています。 © 2026 TechnologyAdvice. 無断転載を禁じます

広告主に関する開示:このサイトに掲載されている製品の一部は、TechnologyAdvice が報酬を受け取っている企業のものです。この報酬は、製品がこのサイトのどこにどのように表示されるか(表示される順序など)に影響する場合があります。TechnologyAdvice は、市場で入手可能なすべての企業やすべての種類の製品を掲載しているわけではありません。